Nigeria: Adherence partners give short-term boost, but no long-term benefit - study

People with HIV who selected treatment partners to support their adherence were more likely to return to the clinic to collect further doses of antiretrovirals, and showed a higher rate of viral suppression after six months of treatment, but showed no longer-lasting advantage in terms of viral suppression, CD4 cell counts or mortality, Nigerian and American researchers report in the Journal of Acquired Immune Deficiency Syndromes.